ロード中...
HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
Overexpression of the human epidermal growth factor receptor (HER)-2 oncogenic receptor tyrosine kinase, which occurs in 25% of breast cancers, portends poor clinical outcome and consequently represents an attractive target for therapeutic intervention. Small molecule tyrosine kinase inhibitors that...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1868927/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr1652 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|